Kenneth S. Ramos, MD, PhD

Executive Director, Texas A&M Institute of Biosciences and Technology

Kenneth S. Ramos, MD, PhD, is an accomplished physician-scientist and transformational leader. He is a Lifetime Associate of the National Academy of Sciences and an elected member of the National Academy of Medicine. He is internationally recognized for his scientific contributions to genomics, precision medicine, and toxicology. 

Dr. Ramos rejoined Texas A&M University in 2019 as Executive Director of the Texas A&M Institute of Biosciences and Technology (IBT). Under his leadership, IBT has experienced significant growth in faculty recruitment, extramural research funding, and the breadth of its research portfolio. Key examples of IBT’s growing impact include:

• Opening of the TMC3 Collaborative Research Building located at Helix Park
• Development of a Clinical Research Initiative
• Launch of the Dementia and Alzheimer’s Research Initiative

In 2023, Dr. Ramos was awarded a $6 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to establish the Texas A&M Regional Excellence in Cancer (TREC) Center. Through this initiative, nine early-career investigators have been recruited and mentored, and two innovative platforms focused on molecular data analysis and clinicogenomics have been established. 

Dr. Ramos has also strengthened IBT’s collaborations with leading institutions within the Texas Medical Center, including The University of Texas MD Anderson Cancer Center and Houston Methodist Hospital. In addition, he has promoted interdisciplinary research and expanded opportunities for joint faculty appointments across Texas A&M University, including the College of Engineering, the School of Engineering Medicine, and the College of Agriculture and Life Sciences. These efforts have strengthened institutional partnerships, fostered cross-disciplinary collaboration, and expanded IBT’s capacity to advance biomedical research and improve human health.